Comparative Efficacy of CUS, CXR and CAD in TB Diagnosis in LMIC
Launched by UNIVERSITY OF BARI · May 7, 2024
Trial Information
Current as of June 18, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well different imaging methods can diagnose pulmonary tuberculosis (TB), a serious lung infection that is still a big health issue in many low- and middle-income countries. The researchers want to compare Chest Ultrasound (CUS), Chest X-ray (CXR), and a computer-aided detection (CAD) score to see which method is better at finding TB in people who are showing symptoms and in their family members who may have been exposed.
To be part of this study, participants need to be over 5 years old and able to understand and agree to take part in the trial. They must also need a diagnosis of pulmonary TB within a week, either through lab tests or imaging. Those who have started TB treatment in the past week or who decide to withdraw their consent will not be able to participate. While the trial is not yet recruiting participants, it aims to improve how TB is diagnosed, which could lead to better treatment for many people in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects older than 5 years old.
- • Capacity to provide informed consensus.
- • Condition requiring a diagnosis of pulmonary tuberculosis within 7 days, with either microbiologically or radiologically criteria (index case), or being the household contact reported by an index case.
- Exclusion Criteria:
- • Exposure to any antitubercular treatment prior 7 days than the enrollment after the initiation of clinic
- • Withdraw of the informed consent
About University Of Bari
The University of Bari, a prestigious academic institution located in Bari, Italy, is dedicated to advancing medical research and education. With a strong emphasis on innovation and interdisciplinary collaboration, the university conducts clinical trials aimed at improving patient outcomes and contributing to the global body of medical knowledge. Leveraging its expertise in various fields of healthcare, the University of Bari fosters an environment that prioritizes ethical practices, scientific rigor, and the development of new therapeutic strategies, ultimately enhancing the quality of life for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported